NCT06110962 Detecting Heart Rate, Respiration, and Sleep With the Sleeptracker-AI Under-mattress Monitor
| NCT ID | NCT06110962 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Woolcock Institute of Medical Research |
| Condition | OSA |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-07-10 |
| Primary Completion | 2025-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-07-10 with a primary completion date of 2025-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to simultaneously acquire sleep and breathing data using the under-mattress Sleeptracker (The Sleeptracker-AI Monitor (Fullpower Technologies, California, USA) during routine PSGs in patients who attend the Woolcock Institute for undergoing investigation for possible obstructive sleep apnoea (OSA).
Eligibility Criteria
Inclusion Criteria: * Adults aged 20-90 years old at time of assessment. * Attending the Woolcock Institute for an overnight sleep study for investigation of sleep apnoea. * Able to give informed consent. * Fluent in English. Exclusion Criteria: * Unable to understand study procedure. * Unable to sign informed consent form.
Contact & Investigator
Craig Phillips, PhD
PRINCIPAL INVESTIGATOR
Woolcock Institute of Medical Research
Frequently Asked Questions
Who can join the NCT06110962 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 90 Years, studying OSA. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06110962 currently recruiting?
Yes, NCT06110962 is actively recruiting participants. Contact the research team at camilla.hoyos@mq.edu.au for enrollment information.
Where is the NCT06110962 trial being conducted?
This trial is being conducted at Macquarie Park, Australia.
Who is sponsoring the NCT06110962 clinical trial?
NCT06110962 is sponsored by Woolcock Institute of Medical Research. The principal investigator is Craig Phillips, PhD at Woolcock Institute of Medical Research. The trial plans to enroll 100 participants.